Playlist
Turkmenistan Gains a New Air Link: S7 Airlines to Launch Novosibirsk–Ashgabat Flights in 2026
26 Dec. 05:08S7 Airlines has announced the launch of a new international route connecting Novosibirsk with Ashgabat, further strengthening air connectivity with Turkmenistan. Ticket sales have already begun, with the first flight scheduled for March 31, 2026. The service will operate weekly on Tuesdays.
Flights will depart from Tolmachevo Airport in Novosibirsk at 12:55 AM, arriving in Ashgabat at 3:00 AM local time. The flight duration is approximately 4 hours and 5 minutes, and the route will be operated using Airbus A320 aircraft.
Travelers heading to Turkmenistan can choose between “Standard” and “Plus” fare options, each offering different baggage allowances and ticket change or refund conditions.
Return flights from Ashgabat to Novosibirsk will also take place on Tuesdays, with departure at 4:30 AM and arrival at 10:15 AM. The journey time on the return leg is estimated at 3 hours and 45 minutes.
Depending on the fare, passengers may select additional services such as checked baggage, preferred seating, or cabin class upgrades. S7 Airlines already operates regular flights on the Moscow–Ashgabat route, continuing to expand its presence in Turkmenistan. Full details and current pricing are available on the airline’s official website.
Also read
Simple Vitamin Shows Surprising Results in Pre-Cancerous Blood Conditions, Study Finds
Today in 02:02Daily high-dose supplementation of vitamin C can significantly reduce mortality risks and help prevent severe medical complications in patients with pre-cancerous blood conditions. Researchers from the Van Andel Institute in the United States and Copenhagen University Hospital in Denmark reached this conclusion following a comprehensive three-year follow-up study. The international "EVITA" trial involved volunteers who were administered 1,000 mg of vitamin C daily over the course of a year, while a control group received a placebo.
Although initial hypotheses suggested vitamin C might directly inhibit abnormal cell proliferation, researchers found its primary benefit lay in strengthening the body, reducing systemic inflammation, and lowering rates of anemia, pneumonia, and internal bleeding. Over the three-year observation period, the vitamin C group exhibited a significantly higher survival rate compared to the placebo group. While experts emphasize that these findings remain preliminary and require larger clinical trials before reshaping formal medical treatment protocols, vitamin C continues to show promising potential in supportive patient care.
Also read
Blitz